These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 8494067

  • 1. Cardiovascular complications of ECT in depressed patients with cardiac disease.
    Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA.
    Am J Psychiatry; 1993 Jun; 150(6):904-9. PubMed ID: 8494067
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular morbidity in high-risk patients during ECT.
    Rice EH, Sombrotto LB, Markowitz JC, Leon AC.
    Am J Psychiatry; 1994 Nov; 151(11):1637-41. PubMed ID: 7943453
    [Abstract] [Full Text] [Related]

  • 3. Depression, heart disease, and tricyclic antidepressants.
    Roose SP, Glassman AH, Dalack GW.
    J Clin Psychiatry; 1989 Jul; 50 Suppl():12-6; discussion 17. PubMed ID: 2661547
    [Abstract] [Full Text] [Related]

  • 4. The effects of electroconvulsive therapy on serial electrocardiograms and serum cardiac enzyme values. A prospective study of depressed hospitalized inpatients.
    Dec GW, Stern TA, Welch C.
    JAMA; 1985 May 03; 253(17):2525-9. PubMed ID: 3981780
    [Abstract] [Full Text] [Related]

  • 5. [Cardiac safety of electroconvulsive therapy in an elderly patient--a case report].
    Karakuła-Juchnowicz H, Próchnicki M, Kiciński P, Olajossy M, Pelczarska-Jamroga A, Dzikowski M, Jaroszyński A.
    Pol Merkur Lekarski; 2015 Oct 03; 39(232):223-6. PubMed ID: 26608489
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of bupropion in depressed patients with heart disease.
    Roose SP, Dalack GW, Glassman AH, Woodring S, Walsh BT, Giardina EG.
    Am J Psychiatry; 1991 Apr 03; 148(4):512-6. PubMed ID: 1900980
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
    Veith RC, Raskind MA, Caldwell JH, Barnes RF, Gumbrecht G, Ritchie JL.
    N Engl J Med; 1982 Apr 22; 306(16):954-9. PubMed ID: 7038497
    [Abstract] [Full Text] [Related]

  • 8. Cardiac rhythm management devices and electroconvulsive therapy: a critical review apropos of a depressed patient with a pacemaker.
    Kokras N, Politis AM, Zervas IM, Pappa D, Markatou M, Katirtzoglou E, Papadimitriou GN.
    J ECT; 2011 Sep 22; 27(3):214-20. PubMed ID: 21206373
    [Abstract] [Full Text] [Related]

  • 9. The identification and management of patients with a high risk for cardiac arrhythmias during modified ECT.
    Gerring JP, Shields HM.
    J Clin Psychiatry; 1982 Apr 22; 43(4):140-3. PubMed ID: 7068545
    [Abstract] [Full Text] [Related]

  • 10. Reduced length and cost of hospital stay for major depression in patients treated with ECT.
    Markowitz J, Brown R, Sweeney J, Mann JJ.
    Am J Psychiatry; 1987 Aug 22; 144(8):1025-9. PubMed ID: 3605424
    [Abstract] [Full Text] [Related]

  • 11. Labetalol in the control of cardiovascular responses to electroconvulsive therapy in high-risk depressed medical patients.
    Stoudemire A, Knos G, Gladson M, Markwalter H, Sung YF, Morris R, Cooper R.
    J Clin Psychiatry; 1990 Dec 22; 51(12):508-12. PubMed ID: 2258364
    [Abstract] [Full Text] [Related]

  • 12. Cardiac arrhythmias induced by ECT in elderly psychiatric patients: experience with 48-hour Holter monitoring.
    Huuhka MJ, Seinelä L, Reinikainen P, Leinonen EV.
    J ECT; 2003 Mar 22; 19(1):22-5. PubMed ID: 12621273
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular complications of ECT.
    Kellner CH, Beale MD.
    Am J Psychiatry; 1994 May 22; 151(5):789-90; author reply 791. PubMed ID: 8166340
    [No Abstract] [Full Text] [Related]

  • 14. Intra-individual open comparison of burst-suppression-isoflurane-anaesthesia versus electroconvulsive therapy in the treatment of severe depression.
    Engelhardt W, Carl G, Hartung E.
    Eur J Anaesthesiol; 1993 Mar 22; 10(2):113-8. PubMed ID: 8462536
    [Abstract] [Full Text] [Related]

  • 15. Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health.
    Paul SM, Extein I, Calil HM, Potter WZ, Chodoff P, Goodwin FK.
    Am J Psychiatry; 1981 Apr 22; 138(4):486-9. PubMed ID: 6111228
    [Abstract] [Full Text] [Related]

  • 16. Caffeine-modified electroconvulsive therapy in depressed patients with medical illness.
    Lurie SN, Coffey CE.
    J Clin Psychiatry; 1990 Apr 22; 51(4):154-7. PubMed ID: 2324078
    [Abstract] [Full Text] [Related]

  • 17. Treating the depressed patient with cardiovascular problems.
    Roose SP, Dalack GW.
    J Clin Psychiatry; 1992 Sep 22; 53 Suppl():25-31. PubMed ID: 1522077
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular morbidity and ECT.
    Stoudemire A.
    Am J Psychiatry; 1995 Nov 22; 152(11):1697-8. PubMed ID: 7485653
    [No Abstract] [Full Text] [Related]

  • 19. The influence of concomitant antidepressant medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.
    Baghai TC, Marcuse A, Brosch M, Schüle C, Eser D, Nothdurfter C, Steng Y, Noack I, Pietschmann K, Möller HJ, Rupprecht R.
    World J Biol Psychiatry; 2006 Nov 22; 7(2):82-90. PubMed ID: 16684680
    [Abstract] [Full Text] [Related]

  • 20. Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: a chart review.
    Nakajima S, Ishida T, Akaishi R, Takahata K, Kitahata R, Uchida H, Suzuki T, Takeuchi H, Nomura K, Nakagawa A, Watanabe K, Kashima H.
    J ECT; 2009 Sep 22; 25(3):178-81. PubMed ID: 19710625
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.